For the year ending 2025-12-31, BMRN made $3,221,253K in revenue. $348,901K in net income. Net profit margin of 10.83%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total revenues | 3,221,253 | 2,853,915 | 2,419,226 | 2,096,039 |
| Cost of sales | 717,442 | 580,235 | 514,854 | 483,669 |
| Research and development | 921,930 | 747,184 | 746,773 | 649,606 |
| Selling, general and administrative | 1,153,017 | 1,009,025 | 937,291 | 854,009 |
| Intangible asset amortization | 19,386 | 43,257 | - | - |
| Intangible asset amortization and contingent consideration | - | - | 62,211 | 67,193 |
| Gain on sale of nonfinancial assets | 0 | 10,000 | 0 | 108,000 |
| Total operating expenses | 2,811,775 | 2,369,701 | 2,261,129 | 1,946,477 |
| Income from operations | 409,478 | 484,214 | 158,097 | 149,562 |
| Interest income | 74,904 | 74,883 | 58,339 | 18,034 |
| Interest expense | 10,899 | 12,666 | 17,335 | 15,970 |
| Other income (expense), net | 8,997 | -4,668 | -10,538 | -2,050 |
| Income before income taxes | 482,480 | 541,763 | 188,563 | 149,576 |
| Provision for income taxes | 133,579 | 114,904 | 20,918 | 8,015 |
| Net income | 348,901 | 426,859 | 167,645 | 141,561 |
| Basic EPS | 1.82 | 2.25 | 0.89 | 0.76 |
| Diluted EPS | 1.8 | 2.21 | 0.87 | 0.75 |
| Basic Average Shares | 191,787,000 | 190,027,000 | 187,834,000 | 185,266,000 |
| Diluted Average Shares | 197,394,000 | 196,708,000 | 191,595,000 | 188,963,000 |
BIOMARIN PHARMACEUTICAL INC (BMRN)
BIOMARIN PHARMACEUTICAL INC (BMRN)